Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

7.63p
   
  • Change Today:
    -0.88p
  • 52 Week High: 20.25
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 380.34m
  • Volume: 346,442
  • Market Cap: £29.00m
  • Beta: 0.23

Eden Research signs exclusive deal with Corteva Agriscience

By Josh White

Date: Wednesday 12 May 2021

LONDON (ShareCast) - (Sharecast News) - Crop protection, animal health and consumer products bio-control technology company Eden Research announced the signing of an exclusive commercialisation, supply and distribution agreement with Corteva Agriscience on Wednesday, for its first seed treatment product.
The AIM-traded firm said the agreement followed successful evaluations of its products and technology by Corteva for select seed treatment applications since late 2019.

It said the agreement granted exclusive rights to Corteva for the development, commercialisation and distribution of Eden's first seed treatment product for use in the European Union, the United Kingdom and Serbia.

The product would be based on Eden's registered active ingredients delivered using its novel, patented 'Sustaine' encapsulation technology based on "natural, plastic-free biodegradable microspheres".

Eden and Corteva intended to collaborate on the evaluation of additional uses of Eden's products and technology in the seed treatment market, which was worth around $6.5bn (£4.6bn) annually, with an estimated annual growth rate of between 10% and 12%.

The board described it as a "significant" corporate milestone for Eden, marking its first foray into the use of its active ingredients and Sustaine technology in seed treatments, and the first use of its products and technology on broad acre crops, with "promising" future revenue potential.

Eden Research said the announcement did not change management's expectations in the short term.

"The agreement with Corteva is a defining moment for Eden and clearly demonstrates the next major step in the development of a new product in the significant seed treatment market, whilst also expanding our product coverage to broad acre crops," said chief executive officer Sean Smith.

"Corteva is one of the largest agriculture input companies in the world and has extensive expertise in the seed treatments field.

"We are delighted to be working with Corteva to help meet the needs of farmers who are increasingly aware of the need to source sustainable farming inputs to ensure a greener future."

Smith said that against the backdrop of a growing consumer sustainability agenda, the firm was "excited" about what its products and technologies could offer food producers.

"This is just one of the first steps in realising our ambitions within agriculture and beyond, and we are very pleased to support global efforts to bring sustainable chemistry to market for important, consumer-facing uses."

At 1607 BST, shares in Eden Research were down 10.69% at 13.62p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 7.63p
Change Today -0.88p
% Change -10.29 %
52 Week High 20.25
52 Week Low 7.25
Volume 346,442
Shares Issued 380.34m
Market Cap £29.00m
Beta 0.23

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.94% below the market average9.94% below the market average9.94% below the market average9.94% below the market average9.94% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average
Price Trend
62.17% below the market average62.17% below the market average62.17% below the market average62.17% below the market average62.17% below the market average
53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average53.33% below the sector average
Income Not Available
Growth
42.82% below the market average42.82% below the market average42.82% below the market average42.82% below the market average42.82% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

Eden Research Dividends

No dividends found

Trades for 07-Dec-2021

Time Volume / Share Price
16:28 1,558 @ 7.70p
16:24 54,877 @ 7.75p
16:09 37,500 @ 7.60p
15:40 20,000 @ 8.00p
14:24 2,432 @ 8.06p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page